Development of a 99m Tc-Labeled...

Cancer Biotherapy & Radiopharmaceuticals 2018 / 02

Development of a 99m Tc-Labeled CXCR4 Antagonist Derivative as a New Tumor Radiotracer

Mikaeili, Azadeh, Erfani, Mostafa, Shafiei, Mohammad, Kobarfard, Farzad, Abdi, Khosrou, Sabzevari, Omid
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Cancer Biotherapy and Radiopharmaceuticals
DOI:
10.1089/cbr.2017.2226
Date:
February, 2018
File:
PDF, 294 KB
english, 2018
Conversion to is in progress
Conversion to is failed